D. E. Shaw & Co., Inc. - NORTHWEST BIOTHERAPEUTICS IN ownership

NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 9 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of NORTHWEST BIOTHERAPEUTICS IN
ValueSharesWeighting
Q1 2016$52,000
-22.4%
35,775
+70.4%
0.00%
Q4 2015$67,000
-87.2%
20,995
-74.8%
0.00%
-100.0%
Q3 2015$522,000
-23.2%
83,476
+21.9%
0.00%0.0%
Q2 2015$680,000
+601.0%
68,498
+422.6%
0.00%
Q1 2015$97,000
+24.4%
13,106
-10.7%
0.00%
Q4 2014$78,000
-39.5%
14,672
-43.0%
0.00%
Q3 2014$129,000
-86.4%
25,725
-81.8%
0.00%
-100.0%
Q2 2014$949,000141,3970.00%
Other shareholders
NORTHWEST BIOTHERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Moloney Securities Asset Management, LLC 352,660$320,8150.06%
Opus Capital Group, LLC 60,150$550.01%
AlphaMark Advisors, LLC 14,007$130.01%
ADVISORS MANAGEMENT GROUP INC /ADV 10,270$90.00%
LEE DANNER & BASS INC 20,000$180.00%
Williams Jones Wealth Management, LLC. 44,000$40,0270.00%
MAI Capital Management 20,000$18,1940.00%
Bartlett & Co. LLC 4,292$40.00%
Coston, McIsaac & Partners 1,000$00.00%
View complete list of NORTHWEST BIOTHERAPEUTICS IN shareholders